Quick answer: "Sema" is shorthand for semaglutide, a 31-amino-acid GLP-1 receptor agonist designed with a fatty-diacid side chain that binds albumin and extends its half-life. Approved medicines containing it are made by its originator, Novo Nordisk. This guide is about the research compound sold for laboratory work, which is not the approved product, and it makes no claims about use in people.
What semaglutide is
Semaglutide is a peptide analog of glucagon-like peptide 1 (GLP-1), an incretin hormone that acts on the GLP-1 receptor. The native hormone is cleared within minutes because an enzyme called DPP-4 cuts it and the kidneys remove it. Semaglutide was designed to resist both. Its sequence is about 94 percent identical to human GLP-1, with an aminoisobutyric acid (Aib) substituted at position 8 to block DPP-4, an arginine at position 34, and a C18 fatty diacid chain attached to the lysine at position 26 through a short spacer.
That fatty chain is the key innovation. It binds strongly to albumin in plasma, which protects the peptide from clearance and gives it a half-life measured in days, not minutes, in published pharmacology. Our structure and synthesis article walks through the sequence, and the discovery and history article tells how the design came about.
What "sema" means
"Sema" is simply shorthand for semaglutide, as "tirz" is for tirzepatide and "reta" for retatrutide. Because brand-style names are sometimes used for research material, it helps to match a listing to the compound name, the vial size and the declared content. We supply semaglutide as a 10 mg research vial.
The receptor profile
Semaglutide is a selective GLP-1 receptor agonist. That makes it the simplest member of the incretin-family group we describe: one receptor, one signalling axis. Tirzepatide adds the GIP receptor and retatrutide adds the glucagon receptor on top of that. Researchers use semaglutide as a benchmark for exactly that reason, because a one-receptor reference makes the effect of each added receptor easier to read.
Our mechanism of action article goes through the signalling steps, and the four-compound comparison sets the family side by side.
Research compound versus approved medicine
It is worth being direct about this. Semaglutide is the active ingredient in medicines approved by regulators and made by Novo Nordisk. Those products are manufactured and tested under pharmaceutical rules and are outside the scope of this site. The semaglutide supplied by V8 Peptides is sold only for laboratory research, such as in vitro assays and preclinical models. It is not the approved product, it is not a substitute for it, and nothing here is guidance for use in people or animals.
That is also why documentation matters so much. Approved medicines have regulatory release testing behind them. Research material has the supplier's own testing, and the buyer has to read the certificate to know what is in the vial.
Why a lipidated peptide is hard to make well
A 31-residue peptide with a non-natural amino acid and a lipid side chain needs many synthesis steps, and every step has a small failure rate that compounds along the chain. The result is a mixture of the target and a set of closely related impurities: sequences with a missing residue, truncated chains, and products where the fatty chain is attached in the wrong place or not at all. Purification separates them, but it also discards material, which drives up the cost of a clean batch.
A single headline purity number can hide this. The chromatogram shows whether there is one dominant peak or a cluster of shoulders and small peaks. Our semaglutide purity testing article describes what to look for, and understanding HPLC purity explains the trace in general terms.
What to check on a semaglutide listing
- A certificate for the lot, naming the lot code, test date and laboratory.
- Measured HPLC purity with the chromatogram attached, not only a specification limit.
- Measured content, compared with the label. This matters because purity says nothing about how much peptide is in the vial.
- Endotoxin and sterility, which are as important as purity for cell-based work.
- Verifiability. The best reports can be checked with the laboratory that issued them.
If the format is new to you, how to read a COA walks through a certificate line by line, and the semaglutide and tirzepatide buyer's guide applies the checklist to both. Sourcing notes for this compound are in where to buy semaglutide.
What affects the price of research semaglutide
The cost of a research vial follows from a few technical factors. A 31-residue peptide with a non-natural amino acid and a fatty-diacid chain takes many synthesis steps, and each step loses a little yield. Purification then discards the impure fractions. Testing adds a further cost per lot, particularly if it includes measured content, endotoxin and sterility rather than a purity figure alone. A listing far below the market usually saves money in one of those steps, so it is a reason to read the certificate more closely, not a bargain.
Common points of confusion
Three confusions come up repeatedly. First, semaglutide and the brand-name medicines made from it are not the same thing as the research compound sold for laboratory work, a point our brand chemistry article explains from the chemistry side. Second, semaglutide is often assumed to be interchangeable with tirzepatide, although they differ in receptor profile and in structure; our comparison lays out the differences. Third, purity is often read as content. A sample can be highly pure and still contain less peptide than its label suggests, which is why measured content belongs on every certificate.
Where it came from
Semaglutide came out of a long programme at Novo Nordisk to turn the short-lived native hormone into a molecule with a durable profile. The earlier compound in that line, liraglutide, used a smaller fatty acid and acted for about a day. Moving to a longer diacid chain and adding the Aib substitution produced a molecule that stays active for roughly a week in published pharmacology. Reading the original design papers is worthwhile for anyone who works with the compound, because they explain why each substitution is there and what happens to potency if a batch has them in the wrong place. Our discovery and history article summarizes that story.
Storage and handling
The compound is supplied as a lyophilized powder. General laboratory practice is to keep the sealed vial refrigerated, protected from light, heat and moisture, and to avoid repeated temperature cycling. Once reconstituted for an assay, a peptide solution is less stable than the dry powder, so working solutions are best made fresh. The reconstitution and storage article has the details, and the calculator guide helps with concentration arithmetic.
What V8 Peptides publishes for semaglutide
We supply semaglutide as a 10 mg research vial. We have not yet published a certificate for this product. We have asked our laboratory supply chain for reports on every product that lacks one, and semaglutide is on that list. When it arrives it will go on the COA page and the product page will be updated. The certificates we do have, such as the one for tirzepatide, can be verified directly on the laboratory's site.
Frequently asked questions
What does "sema" mean?
It is community shorthand for semaglutide, like "tirz" for tirzepatide and "reta" for retatrutide.
What kind of molecule is semaglutide?
A 31-amino-acid GLP-1 analog with an Aib substitution at position 8 and a C18 fatty-diacid chain on the lysine at position 26, which binds albumin and extends its half-life.
Is research semaglutide the same as the approved medicine?
No. The approved medicines are made by Novo Nordisk under pharmaceutical controls. Research material is sold for laboratory use only, and nothing here is guidance for use in people or animals.
How does it differ from tirzepatide and retatrutide?
Semaglutide acts on one receptor, the GLP-1 receptor. Tirzepatide adds the GIP receptor, and retatrutide adds the glucagon receptor as well.
Why is purity hard to verify?
The peptide is long and lipidated, so synthesis creates many similar impurities. Reading the chromatogram matters more than a single purity number.
What should a COA show?
Lot code, test date, laboratory, measured HPLC purity with the chromatogram, measured content, and endotoxin and sterility results, ideally verifiable with the lab.
Does V8 Peptides publish a COA for semaglutide?
Not yet. We have requested one and will post it on the COA page when it arrives.
Is this guide advice for use in people?
No. Semaglutide from V8 Peptides is supplied for laboratory research only.
Where to go next
For a fuller picture of the compound, start with the semaglutide research overview and the research FAQ. To check the certificates we publish, visit the COA page.
References
- Lau J, et al. Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. Journal of Medicinal Chemistry. 2015;58(18):7370-7380.
- Knudsen LB, Lau J. The discovery and development of liraglutide and semaglutide. Frontiers in Endocrinology. 2019;10:155.
- Willard FS, et al. Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. JCI Insight. 2020;5(17):e140532.
For laboratory research use only. Not for human or animal consumption. Not a drug, food or cosmetic. This article is educational and describes published research; it makes no claims about outcomes in people or animals.